research collaboration agreement

OXFORD: Sensyne Health plc, the UK Clinical AI company, has signed a research collaboration agreement with Bristol Myers Squibb (BMS). Initially the collaboration will focus on applying Sensyne’s proprietary machine learning to conduct research into disease progression and patient stratification…